Page 14 - Orrin Devinsky News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Personalized models superior to population-based estimates for predicting SUDEP ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS You've successfully added to your alerts. You will receive an email when new content is published. Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Models provided more accurate predictions of ris...

Search jobs Silver Spike Acquisition Corp II Announces Pricing of $250 Million Initial Public Offering NEW YORK--(BUSINESS WIRE)--Silver Spike Acquisition Corp II (the “Company”) announced today that it priced its initial public offering of 25,000,000 units at $10.00 per unit. The units are expected to be listed on The Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “SPKBU” beginning on March 11, 2021. Each unit consists of one Class A ordinary share and one-fourth of one redeemable warrant. Each whole warrant entitles the holder thereof...

Silver Spike Acquisition Corp II (NASDAQ:SPKBU) is poised to debut on the Nasdaq ...

Study Maps Key Proteins Linked to Epilepsy, Revealing New Drug Targets News provided by Share this article Share this article NEW YORK, March 9, 2021 /PRNewswire/ -- An analysis of adult human brain tissue reveals over 900 proteins tied to epilepsy. The brain disorder, estimated to afflict more than 3 million Americans, is mostly known for symptoms of hallucinations, dreamlike states, and uncontrolled, often disabling bodily seizures. Led by researchers at NYU Grossman School of Medicine, the study examined molecular differences among the brains of 14 epilepsy patients and another group of 14...

Shares of GW Pharmaceuticals PLC - ADR (NASDAQ: GWPH) spiked higher by more than 5 percent early Thursday morning after the company reported that data from a physician-led study into Epidiolex "reduced seizure frequency" across multiple drug-resistant epilepsy syndromes and seizure types and was "... Read More... Don't Miss Any Updates! News Directly in Your Inbox Subscribe to: